Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Berkeley Street, 19 Th Floor, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
resTORbio, Inc. (to 8/21/2020)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % -26.8%
Debt-to-equity 17.2 % +33.9%
Return On Equity -64.8 % -80%
Return On Assets -55.3 % -73.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.2M shares +91.3%
Common Stock, Shares, Outstanding 82.2M shares +91.3%
Entity Public Float 76.7M USD -82.1%
Common Stock, Value, Issued 8K USD +100%
Weighted Average Number of Shares Outstanding, Basic 79.1M shares +84.1%
Weighted Average Number of Shares Outstanding, Diluted 79.1M shares +84.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 103M USD +22.1%
General and Administrative Expense 26.9M USD +3.38%
Operating Income (Loss) -150M USD -35.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -140M USD -32.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -140M USD -32.8%
Earnings Per Share, Basic -2.94 USD/shares -15.7%
Earnings Per Share, Diluted -2.94 USD/shares -16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 248M USD +6.89%
Other Assets, Current 613K USD +20%
Assets, Current 250M USD +6.62%
Property, Plant and Equipment, Net 25.4M USD -15%
Operating Lease, Right-of-Use Asset 16.6M USD -15.5%
Goodwill 0 USD -100%
Other Assets, Noncurrent 691K USD -37.7%
Assets 293M USD -3.9%
Accounts Payable, Current 2.54M USD -7.46%
Employee-related Liabilities, Current 4.12M USD +9.64%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 17.5M USD -3.5%
Operating Lease, Liability, Noncurrent 16.7M USD -18.7%
Other Liabilities, Noncurrent 116K USD 0%
Liabilities 34.3M USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -409M USD -52%
Stockholders' Equity Attributable to Parent 259M USD -2.78%
Liabilities and Equity 293M USD -3.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD +5.17%
Net Cash Provided by (Used in) Financing Activities 111M USD
Net Cash Provided by (Used in) Investing Activities -239K USD +87.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 82.2M shares +91.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 87.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 248M USD +6.89%
Deferred Tax Assets, Valuation Allowance 99.1M USD +10.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 103M USD +8.24%
Operating Lease, Liability 20M USD -14.7%
Payments to Acquire Property, Plant, and Equipment 239K USD -87.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.8M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid 24.5M USD
Property, Plant and Equipment, Gross 41.9M USD +5.05%
Operating Lease, Liability, Current 3.32M USD +12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.5M USD -22.6%
Deferred Tax Assets, Operating Loss Carryforwards 65.6M USD -4.23%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 18.5M USD +89.2%
Operating Lease, Payments 1.5M USD -31.8%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3.68M USD -32.4%
Share-based Payment Arrangement, Expense 21.2M USD +20.7%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 8K USD -90.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%